Related Experiment Video
Updated: Feb 4, 2026
05:18
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
Published on: November 22, 2024
1.5K
The elderly as a target for obesity treatment
1a Department of Internal Medicine, Hospital Hochzirl, A-6170 Zirl, Austria.
Expert Review of Endocrinology & Metabolism
|October 9, 2018
Summary
Obesity in older adults is rising. Combining nutrition and exercise improves function, while medication and surgery have limited evidence or high risks in the elderly.
Area of Science:
- Gerontology
- Metabolic Health
- Obesity Medicine
Background:
- Increasing prevalence of obesity in the elderly population.
- Need for effective obesity management strategies in older adults to improve health outcomes.
- Current therapeutic options for elderly obesity are limited in evidence or carry significant risks.
Purpose of the Study:
- To review the current evidence on obesity management in the elderly.
- To highlight the importance of a comprehensive geriatric assessment in treatment planning.
- To discuss the efficacy and safety of different therapeutic approaches.
Main Methods:
- Review of clinical studies and evidence regarding nutritional intervention, physical exercise, medication, and bariatric surgery for elderly obesity.
- Emphasis on the role of the comprehensive geriatric assessment (CGA).
- Analysis of CGA components including body composition, nutritional status, functional, and cognitive capacities.
Main Results:
- Combination of nutritional intervention and physical exercise shows advantage in improving functional status.
- Limited evidence exists for the efficacy and safety of weight-reduction medications in the elderly.
- Risks associated with bariatric surgery generally outweigh potential benefits in this population.
Conclusions:
- Nutritional intervention and physical exercise are key components for managing obesity in the elderly.
- Comprehensive geriatric assessment is crucial for tailoring treatment plans and setting realistic goals.
- Further research is needed to establish safe and effective pharmacological interventions for elderly obesity.
Related Concept Videos
01:24Obesity
1.3K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.3K
01:21Drug Dosing: Obese Patients
263
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
263
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
282
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
282
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
184
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
184
01:27Open Angle Glaucoma: Treatment
997
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
997
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K